期刊文献+

西罗莫司缓释片的制备及其释药因素考察 被引量:2

Preparation of sirolimus sustained-release tables and observe of influence factors on releasing drug
暂未订购
导出
摘要 目的制备西罗莫司缓释片并对其释药因素进行考察。方法采用羟丙基甲基纤维素(HPMC)为基本骨架材料制备了西罗莫司凝胶骨架片,对影响释药的因素,如采用羟丙基甲基纤维素(HPMC)规格、用量、填充剂种类、致孔剂用量、压片压力及释放介质等进行了考察。结果以30%羟丙基甲基纤维素(HPMC K4M)为骨架材料、2%乳糖为致孔剂、微晶纤维素(MCC)为填充剂时,缓释片呈明显一级释放特征。结论该制剂在体外具有良好的缓释效果,且制备工艺简单易行。 Objective To prepare the sirolimus sustained-release tablets and study the influence factor.Methods The sirolimus sustained-release tablets were prepared by HPMC as the matrix material.The effects of viscosity of HPMC,sort of an adhensive amount of a lubricant,and the preparation methods on the release of sirolimus from matrix tablets were observed.Results Based on the results of single factor tests,an optimal self-prepared matrix sustsained-release tablets which contained 30 % HPMC(K4M),2 % lactose and MCC was definited.The release of the drug was an obvious characteristic in first class.Conclusion The tables have desirable sustain-release property in vitro.The preparation process was simple and can be applied in production.
出处 《药学实践杂志》 CAS 2010年第2期126-129,139,共5页 Journal of Pharmaceutical Practice
基金 福建省科技计划项目(2007Y0063)
关键词 西罗莫司 凝胶骨架缓释片 体外释放 羟丙基甲基纤维素(HPMC) sirolimus matrix sustained-release tablets drug release in vitro HPMC
  • 相关文献

参考文献11

二级参考文献119

共引文献99

同被引文献35

  • 1胡连栋,唐星,丁怡,张倩.离心造粒法制备盐酸二甲双胍缓释微丸[J].中国医药工业杂志,2005,36(9):541-544. 被引量:11
  • 2崔宝国,李林军,黄桂华.丙烯酸树脂在微丸包衣中的应用[J].齐鲁药事,2006,25(10):614-616. 被引量:10
  • 3Shaw LM, Holt DW, Oellerich M, el al. Current issues in ther- apeutic drug monitoring of mycophenolic acid: report of a round table discussion [J]. Ther Drug Monit, 2001,23:305- 315.
  • 4Victoria CC, Mary HHE. Mycophenolate mofetil for solid or- gan transplantation: does the evidence support the need for clinical pharmacokinetic monitoring[J]. Therapeutic Drug Mo- nitoring, 2003,25 : 137-157.
  • 5王家威.两种不同剂量药物缓释微丸的研究[D].沈阳:沈阳药科大学,2002.
  • 6Spilman P, Podlutskaya N, Hart MJ,et al. Inhibition of mTOR by rapamycin abblishes cognitive deficits and reduces amyloid-beta levels in amouse model of Alzheimer' s disease [ J ]. PLoS One, 2010, 5 (4) : e9979.
  • 7Emami S, Valizadeh H, Islambulchilar Z, et al. Development and Physicochemical Characterization of Sirolimus Solid Dispersions Prepared by Solvent Evaporation Method[ J], Adv Pharm Bull, 2014, 4 (4) : 369-374.
  • 8Park SM, Kim MS, Park SJ, et al. Novel temperature-triggered liposome with high stability: Formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU) [ J ]. J Control Release, 2013,170(3) :373-379.
  • 9Fu J, Wang D, Wang T, et al. High Entrapment Efficiency of Chitosan/Polylactic Acid/Tripolyphotspate Nanosized Microcapsules for Rapamycin by an Emulsion-Evaporation Approach [ J ]. J Biomed Nanotechnol, 2010, 6(6): 725-728.
  • 10Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability[ J]. Int J Pharm, 2010, 394( 1-2 ) : 179185.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部